MBio Diagnostics Inc., a Boulder, CO-based provider of clinical diagnostics and sample testing, closed a $6.3m Series B funding.
The round was led by unnamed new and existing investors.
The company intends to use the funds for the refinement of the platform and improvements in manufacturing as it executes a partnering strategy to commercialize the technology.
Led by Chris Myatt, CEO, MBio Diagnostics develops the MBio Array System, a portable, multiplex reader that provides lab-quality results in 1 to 20 minutes employing disposable load-and-go cartridges to detect all key analytes including: proteins, cells, nucleic acids, and small molecules.
FinSMEs
22/05/2015